statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced plans to release its financial...

Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024

Key Insights The projected fair value for Insulet is US$183 based on 2 Stage Free Cash Flow to Equity With US$171 share...

Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)

Insulet (PODD) closed the last trading session at $169.18, gaining 3.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street...

Wall Street Analysts See a 38.87% Upside in Insulet (PODD): Can the Stock Really Move This High?

Insulet: Insulating Patients, Investors Still Have To Wait...

Insulet: Insulating Patients, Investors Still Have To Wait

Shares of Insulet Co. (NASDAQ:PODD  Get Free Report) have been given a consensus rating of Moderate Buy by the sixteen analysts that are covering the company, MarketBeat Ratings...

Insulet Co. (NASDAQ:PODD) Receives Consensus Rating of "Moderate Buy" from Analysts

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced that Ana Maria Chadwick has been...

Insulet Appoints Ana Maria Chadwick as Chief Financial Officer

In afternoon trading on Wednesday, Healthcare stocks are the worst performing sector, showing a 0.7% loss. Within that group, Insulet Corp (PODD) and Moderna Inc (MRNA) are two of the days...

Wednesday Sector Laggards: Healthcare, Utilities

Citi analyst Joanne Wuensch has reiterated their bullish stance on PODD stock, giving a Buy rating on March 6. Joanne Wuensch's rating is based on...

Insulet's Growth Trajectory Affirmed with a Buy Rating and Revised Target Price

Insulet Co. (NASDAQ:PODD  Free Report)  Equities researchers at William Blair issued their Q1 2025 EPS estimates for Insulet in a research report issued to clients and investors on...

Insulet Co. to Post Q1 2025 Earnings of $0.62 Per Share, William Blair Forecasts (NASDAQ:PODD)

Investors in Insulet Corp (PODD) saw new options begin trading today, for the July 2025 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time...

PODD July 2025 Options Begin Trading

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Volume	614,615.00
52-Wk High	$331.65
52-Wk Low	$125.82

PODD Insulet Corporation

About

Feed

News

Sentiment

Earnings

Fundamentals